IDPC

Past Events

Results 1093 to 1104 of 1485

3rd City Health International Conference

Amsterdam, Netherlands
2 November 2014 - 3 November 2014
The conference will examine how cities around the globe respond to changing populations and adapt to changing health behaviours.

International drug users' day 2014

World
31 October 2014
International Drug Users' Day is the one day of the year where people who use drugs can celebrate the strength and diversity of our community, our solidarity and our empowerment.

Международный день потребителей наркотиков 2014

мир
31 October 2014
В этот Международный день потребителей наркотиков 2014 мы заявляем, что, чтобы закончить войну с наркотиками мы должны отказаться от идей, которые ведут к запретам и криминализации.

Are crime and violence prevention programs working in Central America?

Washington, D.C. United States
30 October 2014
U.S. taxpayers have been funding citizen security programs in Central America for six years. This event will talk about whether these efforts are having an impact on the crime and violence that has shaken the region and led to unprecedented migration of unaccompanied minors to the United States.

EuroHRN training on drug policies

Vilnius, Lithuania
26 October 2014 - 28 October 2014
The purpose of this training is to train participants around building relationships with stakeholders to strengthen harm reduction at the local level.

10th National Harm Reduction Conference

Baltimore, United States
22 October 2014 - 25 October 2014
This conference will focus on improving best practices of harm reduction in a context in which the totalitarianism of the war on drugs is" melting at the edges".

European conference on hepatitis C and drug use

Berlin, Germany
22 October 2014 - 23 October 2014
This event will bring together key actors on hepatitis C to develop pathways for effective health responses and to open treatment for those who need it.

美国走向大麻合法化趋势对国际的影响

Washington, D.C. United States
17 October 2014 - 17 October 2014
本次论坛将讨论美国对大麻的策略改变所引起的国际反响。专家小组将考虑这一改变对其他国家和国际药物管制制度可能产生的后果。